Welcome to the British Journal of Clinical Psychology, a leading publication in the field of psychology, particularly recognized for its contributions to clinical practice and research since its inception. Published by Wiley, the journal boasts an impressive impact with a Q1 ranking in both Clinical Psychology and Medicine (Miscellaneous) categories as of 2023, evidenced by its placement at rank #65 out of 311 in Scopus for Clinical Psychology, reflecting its impactful and high-quality contributions in the domain. With a history stretching back to 1962 and ongoing publication through 2024, the journal provides a rigorous platform for researchers, professionals, and students to disseminate and engage with innovative studies, methodologies, and clinical insights. Although it does not currently operate under an Open Access model, the journal’s commitment to enhancing knowledge and practice in clinical psychology makes it an indispensable resource for anyone involved in psychological research and practice.

The BULLETIN OF THE MENNINGER CLINIC, an esteemed publication of GUILFORD PUBLICATIONS INC, has been a pivotal resource in the fields of Clinical Psychology and Psychiatry since its inception in 1945. With ISSN 0025-9284 and E-ISSN 1943-2828, this journal is recognized for its commitment to advancing knowledge and practices in mental health. Indexed in Scopus with respectable rankings across various categories, it stands in the Q3 quartile for both Clinical Psychology and Psychiatry and Mental Health, indicating its role as a significant contributor to academic discourse. Although it operates under a subscription model, the journal features a broad spectrum of peer-reviewed articles, case studies, and research findings that are essential for professionals, researchers, and students dedicated to understanding and improving mental health care. The BULLETIN OF THE MENNINGER CLINIC serves as a vital platform for interdisciplinary dialogue, fostering innovative approaches and methodologies that shape the future of mental health treatment and research.

Activitas Nervosa Superior Rediviva is a peer-reviewed journal dedicated to the fields of neuropsychology, physiological psychology, psychiatry, and mental health research. Published by the esteemed SLOVAK ACADEMY OF SCIENCES, INSTITUTE OF NORMAL AND PATHOLOGICAL PHYSIOLOGY, this journal embraces an open-access model, facilitating the dissemination of critical findings and discussions within these evolving fields. With a focus on innovative studies spanning from 2009 to 2024, it provides a vital platform for researchers and professionals seeking to understand the complexities of the nervous system and related disorders. Although currently classified in the fourth quartile across relevant categories including neuropsychology and psychiatric health, the journal’s commitment to publishing quality research contributes significantly to the ongoing discourse among academics and clinicians alike. Activitas Nervosa Superior Rediviva invites scholars to engage with its content and further strengthen the integration of research and practice in mental health and neurological sciences.

Clinical Psychological Science is a premier journal dedicated to advancing the field of clinical psychology. Published by SAGE Publications Inc, this journal serves as a vital resource for researchers, practitioners, and students alike, fostering a dialogue that bridges empirical research and clinical practice. With an impressive impact factor and a distinguished ranking of #16 out of 311 in Clinical Psychology according to Scopus, it occupies a Q1 category in its field, signifying its role as a leader in innovative research and clinical applications since its inception in 2013. With a robust commitment to high-quality peer-reviewed content, Clinical Psychological Science features cutting-edge studies that inform evidence-based practices and offer new insights into psychological assessment and intervention strategies. While not an open access journal, it continues to be an essential platform for disseminating influential findings that shape the future of clinical psychology.

Terapia Psicologica is a distinguished peer-reviewed journal published by the SOCIEDAD CHILENA PSICOLOGIA CLINICA, focusing on the critical fields of Clinical Psychology and Psychiatry and Mental Health. Since its inception in 2008, this journal has emerged as a pivotal platform for disseminating innovative research and clinical practices in mental health, garnering attention in the academic community with its position in the Q3 quartile as of 2023. The journal serves as an invaluable resource for researchers, professionals, and students seeking to advance their understanding of psychological therapies and mental health interventions. Although Terapia Psicologica does not currently provide open access, its comprehensive scope ensures that vital findings reach a broad audience, enhancing the quality and impact of psychological practice across Chile and beyond. With its ISSN 0718-4808, the journal continues to contribute significantly to the evolving discourse in psychology, maintaining its relevance and importance in shaping future research and therapeutic practices.

Iranian Journal of Psychiatry and Behavioral Sciences, published by BRIEFLAND, is a pivotal platform for scholars and practitioners in the fields of psychiatry and behavioral sciences. With its ISSN 1735-8639 and E-ISSN 1735-9287, this journal primarily caters to the Iranian context while fostering a global dialogue on contemporary issues in mental health, behavioral neurology, and biological psychiatry. Since its inception in 2007, the journal has committed to disseminating high-quality research and reviews, thereby contributing to its categorization in the fourth quartile (Q4) for both Behavioral Neuroscience and Biological Psychiatry as of 2023. Although currently lacking an open access model, the journal's accessibility to critical research discussions is vital for enhancing knowledge among researchers, professionals, and students alike. With emerging relevance in the Iranian mental health landscape, it aims to bridge gaps in understanding and promote evidence-based practices from 2007 to 2024 and beyond.

Journal of Evidence-Based Psychotherapies is a pivotal publication focusing on the integration of empirical research and practical applications within the domain of psychotherapy. Published by the International Institute for Advanced Studies in Psychotherapy & Applied Mental Health, this journal plays a significant role in fostering innovative approaches to mental health treatment, contributing to the evidence-based practice that is crucial for enhancing therapeutic outcomes. With an ISSN of 2360-0853 and a commitment to Open Access, the journal provides researchers and practitioners from around the globe with unrestricted access to the latest findings and methodologies in the field. Since its inception in 2014, the journal has consistently aimed to bridge the gap between scientific research and clinical practice, reflecting its overall objectives to promote significant advancements in psychotherapy. Rated in the Q3 category for Clinical Psychology and Q4 for Experimental and Cognitive Psychology, it holds a Scopus rank that underscores its importance in the academic landscape. Situated in Cluj-Napoca, Romania, this journal invites contributions that deepen our understanding of effective therapeutic strategies and address contemporary challenges within mental health.

Rivista di Psichiatria, published by PENSIERO SCIENTIFICO EDITORE, stands as a significant contributor to the field of Psychiatry and Mental Health since its inception in 1975. With an ISSN of 0035-6484 and an E-ISSN of 2038-2502, this esteemed journal offers a platform for rigorous academic discourse and cutting-edge research, helping to shape contemporary psychiatric practices and theories. Currently holding a Q2 designation in Psychiatry and Mental Health based on the 2023 category quartiles, and ranking #197 out of 567 in Scopus, it reflects a commendable 65th percentile among its peers. The journal welcomes contributions that encompass a broad range of topics related to mental health, encouraging contributions from a multidisciplinary approach, which aids in its goal of advancing the understanding and application of psychiatric science. While it is a traditional journal without Open Access options, access to its valuable content can support researchers, clinicians, and students in their pursuit of knowledge and innovation within the field. Situated in Rome, Italy, at VIA SAN GIOVANNI VALDARNO 8, ROME 00138, the journal continues to enhance its rich legacy, promoting the exchange of ideas and fostering collaboration amongst practitioners and scholars alike.

BJPsych Advances is a distinguished journal dedicated to the field of Psychiatry and Mental Health, published by Cambridge University Press. With an ISSN of 2056-4678 and an E-ISSN of 2056-4686, this journal serves as a crucial platform for disseminating high-quality research and advancements in psychiatric science. Holding a position in the Q3 quartile as of 2023, it ranks 330 out of 567 in the Scopus database, representing a significant contribution to the mental health community, with a 41st percentile status. The journal not only covers recent innovations and methodologies but also emphasizes practical applications in clinical settings, making it an essential resource for researchers, practitioners, and students alike. With a commitment to fostering a deeper understanding of psychiatric disorders and their implications, BJPsych Advances plays a vital role in enhancing the standards of mental healthcare across the globe, bridging the gap between academic research and clinical practice.

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.